Cimetidine and granulopoiesis: bone marrow culture studies in normal man and patients with cimetidine-associated neutropenia.
Cimetidine and granulopoiesis: bone marrow culture studies in normal man and patients with cimetidine-associated neutropenia.
复制标题
西咪替丁和粒细胞生成:正常人和西咪替丁相关中性粒细胞减少症患者的骨髓培养研究。
DOI:
10.1111/j.1365-2141.1980.tb05982.x
复制
发表时间:
1980
影响因子:
6.5
通讯作者:
Koeffler,HP
中科院分区:
文献类型:
--
作者:
Fitchen,JH;Koeffler,HP
SummaryWe studied the effect of the H2‐receptor antagonists, cimetidine and metiamide, onin vitromyeloid colony formation by bone marrow cells from seven normal volunteers and two patients with a cimetidine‐associated neutropenia. A cimetidine concentration of 500 μg/ml produced 50% inhibition of normal granulocyte—macrophage colony formation, and 1000 μg/ml of cimetidine completely suppressed proliferation. The inhibitory effect of metiamide occurred at lower concentrations: 50% inhibition at 250 μg/ml and 95% inhibition at 350 μg/ml. Cimetidine had a similar inhibitory effect on colony formation by recovery marrow from the two patients with cimetidine‐associated neutropenia. Treatment of autologous and allogeneic marrows with patients’ acute phase sera and cimetidine failed to show evidence of antibody‐mediated suppression of granulopoiesis. Our results indicate that at sufficiently high concentrations, cimetidine and metiamide inhibit human bone marrow myeloid colony formationin vitro. These findings are consistent with the hypothesis that H2‐receptor antagonists may produce neutropenia in a dose‐related fashion by injury to granulocytic progenitor cellsin vivo.